СТАСЗАК-ЙИРКОВСКИ, Якуб (US),КОБР, Лукас (US),МИКНИС, Грегори, Ф. (US),ХАДСОН, Коллин (US),МОНФРЕГОЛА, Лука (US),ЙИРКОВСКИ, Павел (CZ),МИЛАДА, Збонцакова (CZ),ДЬЮЕКС, Джейсон (US),КАНДАСАМИ, Питчайман
申请号：
RU2019102212
公开号：
RU2019102212A
申请日:
2017.06.29
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a beneficial effect on the inhibition of cancerous cell growth. Methods of administering these compositions are also described.
